Letosteine
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
2-{2-[(2-ethoxy-2-oxoethyl)thio]ethyl}-1,3-thiazolidine-4-carboxylic acid | |
| Identifiers | |
| CAS Number |
53943-88-7 |
| ATC code | R05CB09 (WHO) |
| PubChem | CID 68707 |
| DrugBank |
DB08939 |
| ChemSpider |
61958 |
| UNII |
6MVF9U95DW |
| KEGG |
D07380 |
| Synonyms | 2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid |
| Chemical data | |
| Formula | C10H17NO4S2 |
| Molar mass | 279.378 g/mol |
| |
| |
| | |
Letosteine is a mucolytic patented (U.S. patent 6987120) by Piero del Soldato of Milan, Italy.[1] He filed his application in 2000.
References
| ||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
